Menu Back to 2nd-DIA-Clinical-Operation-Monitoring-Workshop-in-Japan

Program Committee

  • Eri  Sekine
    Eri Sekine Head of Oncology Biometrics and DM Department, Oncology Development Novartis Pharma K.K., Japan
  • Midori  Fujikawa
    Midori Fujikawa Leader, Clinical Research Coordination Dept. Chugai Pharmaceutical Co., Ltd., Japan
  • Mitsuo  Hayashi, MSc
    Mitsuo Hayashi, MSc Director, Site Monitoring, Clinical Operation Area, Japan Development MSD K.K., Japan
  • Keiichi  Inaizumi
    Keiichi Inaizumi Pfizer Japan Inc., Japan
  • Toshiko  Ishibashi, PhD, RN
    Toshiko Ishibashi, PhD, RN Clinical Research Coordinator St. Luke's International Hospital, Japan
  • Mikiro  Kobayashi
    Mikiro Kobayashi Associate Manager, MDC-J Oncology, Development & Medical Affairs Div GlaxoSmithKline K.K., Japan
  • Hiroshi  Kosaku
    Hiroshi Kosaku CMIC Holdings Co., Ltd., Japan
  • Suzuko  Oikawa
    Suzuko Oikawa Director, Clinical Research Bristol-Myers K.K., Japan
  • Satoshi  Saeki, MSc
    Satoshi Saeki, MSc Senior Manager, Immunology and Inflammation Area, Japan Asia Development Astellas Pharma Inc., Japan
  • Norio  Shimazaki
    Norio Shimazaki Manager, Regional Clinical Operation Bristol-Myers K.K., Japan
  • Kazumasa  Sugao
    Kazumasa Sugao Manager, Clinical Development Dept. Mitsubishi Tanabe Pharma Corporation, Japan
  • Kyoji  Tamanoi
    Kyoji Tamanoi Senior Clinical Trial Manager, Clinical Trial Management ICON Japan K.K., Japan
Load More